Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Clinical Research Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Fertil Steril. 2021 May;115(5):1270-1279. doi: 10.1016/j.fertnstert.2020.12.008. Epub 2021 Feb 15.
To study the clinical characteristics and genetic basis of complete androgen insensitivity syndrome (CAIS) in patients from the People's Republic of China. CAIS patients with 46 XY karyotype produce male levels of androgens but present with female external genitalia and secondary sex characteristics. The majority of affected individuals have androgen receptor (AR) gene mutations. This case series explored clinical and molecular characteristics of CAIS patients from the People's Republic of China.
Genomic DNA from peripheral blood of clinically diagnosed CAIS patients was sequenced for mutation in the androgen receptor (AR) gene and steroid 5α-reductase type 2 gene (SRD5A2).
Participants were recruited from Peking Union Medical College Hospital when they came in for consultation.
Thirty patients from unrelated families were recruited.
Data from medical documents recording diagnosis and treatment of these patients were retrospectively collected.
Patient genotypes were determined by sequencing the AR and SRD5A2 genes. Their clinical characteristics were summarized based on symptoms, hormone profiles, operative findings, and pathological results.
Twenty-one patients diagnosed with CAIS had mutations in AR exons. Analysis of AR exons revealed the presence of seven novel mutations (c.58C>T, c.645_652delGGGGGCTC, c.910G>T, c.1078C>T, c.1786T>A, c.2230G>T, and c.2522G>C); of these mutations, 47.6% (10/21) were located in the ligand-binding domain. Gonadal insufficiency was found in one case of CAIS. Among the remaining nine patients, three had SRD5A2 mutations and therefore a steroid 5α-reductase deficiency. No AR or SRD5A2 mutations were detected in the other six patients.
This study broadens the spectrum of known AR gene mutations responsible for CAIS, and implies that there can be more complex underlying causes of CAIS.
研究中国人群完全雄激素不敏感综合征(CAIS)患者的临床特征和遗传基础。CAIS 患者具有 46 XY 核型,产生雄性激素水平,但表现为女性外生殖器和第二性征。大多数受影响的个体都存在雄激素受体(AR)基因突变。本病例系列研究了来自中国的 CAIS 患者的临床和分子特征。
对临床诊断为 CAIS 的患者外周血基因组 DNA 进行雄激素受体(AR)基因和类固醇 5α-还原酶 2 型基因(SRD5A2)突变测序。
参与者是从北京协和医学院医院就诊时招募的。
从 30 个无关家庭中招募了 30 名患者。
回顾性收集记录这些患者诊断和治疗数据的医疗文件。
通过测序 AR 和 SRD5A2 基因确定患者基因型。根据症状、激素谱、手术发现和病理结果总结其临床特征。
21 名诊断为 CAIS 的患者存在 AR 外显子突变。AR 外显子分析显示存在 7 种新突变(c.58C>T、c.645_652delGGGGGCTC、c.910G>T、c.1078C>T、c.1786T>A、c.2230G>T 和 c.2522G>C);其中 47.6%(10/21)位于配体结合域。1 例 CAIS 患者存在性腺功能不全。其余 9 例患者中,有 3 例存在 SRD5A2 突变,因此存在类固醇 5α-还原酶缺乏。另外 6 例患者未检测到 AR 或 SRD5A2 突变。
本研究拓宽了导致 CAIS 的已知 AR 基因突变谱,并提示 CAIS 可能存在更复杂的潜在病因。